Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study | Zendy

Peter Hunyady | Zendy; Lea Streller | Zendy; Darius F. Rüther | Zendy; Sara Reinartz Groba | Zendy; Dominik Bettinger | Zendy; Daniel Fitting | Zendy; Karim Hamesch | Zendy; Jens U. Marquardt | Zendy; Victoria T. Mücke | Zendy; Fabian Finkelmeier | Zendy; Asieb Sekandarzad | Zendy; Tobias Wengenmayer | Zendy; Ayoub Bounidane | Zendy; Felicitas Weiss | Zendy; Kai-Henrik Peiffer | Zendy; Bernhard Schlevogt | Zendy; Stefan Zeuzem | Zendy; Oliver Waidmann | Zendy; Marcus Hollenbach | Zendy; Martha M. Kirstein | Zendy; Johannes Kluwe | Zendy; Fabian Kütting | Zendy; Marcus M. Mücke | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study

Author(s) -

Peter Hunyady,

Lea Streller,

Darius F. Rüther,

Sara Reinartz Groba,

Dominik Bettinger,

Daniel Fitting,

Karim Hamesch,

Jens U. Marquardt,

Victoria T. Mücke,

Fabian Finkelmeier,

Asieb Sekandarzad,

Tobias Wengenmayer,

Ayoub Bounidane,

Felicitas Weiss,

Kai-Henrik Peiffer,

Bernhard Schlevogt,

Stefan Zeuzem,

Oliver Waidmann,

Marcus Hollenbach,

Martha M. Kirstein,

Johannes Kluwe,

Fabian Kütting,

Marcus M. Mücke

Publication year - 2022

Publication title -

clinical infectious diseases

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciac565

Subject(s) - medicine , retrospective cohort study , gastroenterology , liver transplantation , odds ratio , confidence interval , proportional hazards model , transplantation

Secondary sclerosing cholangitis (SSC) is a rare disease with poor prognosis. Cases of SSC have been reported following coronavirus disease 2019 (COVID-SSC). The aim of this study was to compare COVID-SSC to SSC in critically ill patients (SSC-CIP) and to assess factors influencing transplant-free survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research